You have 9 free searches left this month | for more free features.

Oncaspar

Showing 1 - 25 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +5 more
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Oct 28, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

Completed
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Miami, Florida
    University of Miami
Oct 19, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • San Francisco, California
  • +7 more
Aug 5, 2022

Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)

Completed
  • Lymphoblastic Lymphoma
  • San Diego, California
  • +1 more
Jun 7, 2022

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

Terminated
  • Acute Lymphocytic Leukemia
  • Adult Lymphoblastic Lymphoma
  • La Jolla, California
  • +3 more
Apr 26, 2022

B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Ph-Like Acute Lymphoblastic Leukemia
  • Duarte, California
    City of Hope Medical Center
Jul 26, 2022

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)

Recruiting
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021

Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • T Acute Lymphoblastic Leukemia
  • T Lymphoblastic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 11, 2023

Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)

Unknown status
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Dec 16, 2020

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)

Completed
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 1, 2020

Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Los Angeles, California
  • +17 more
Jun 6, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • asparaginase Erwinia chrysanthemi
  • Los Angeles, California
  • +21 more
Jun 1, 2021

Lymphoma Trial in Changsha (pegaspargase, Gemcitabine, Oxaliplatin)

Unknown status
  • Lymphoma
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jan 25, 2020

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in United

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Calaspargase Pegol-mknl
  • +14 more
  • Birmingham, Alabama
  • +26 more
Apr 2, 2021

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Biospecimen Collection
  • +11 more
  • Birmingham, Alabama
  • +152 more
Jan 30, 2023

Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Daunorubicin, Vincristine, PEG-asparaginase)

Completed
  • Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 21, 2019

Acute Lymphoblastic Leukemia Trial in France (pegaspargase 1250 IU/m2 x 2, pegaspargase 2500 IU/m2 x 1)

Recruiting
  • Acute Lymphoblastic Leukemia
  • pegaspargase 1250 IU/m2 x 2
  • pegaspargase 2500 IU/m2 x 1
  • Amiens, France
  • +27 more
Feb 18, 2019